Lataa...
Inhibitory effect of baicalein combined with gemcitabine in human pancreatic cancer cell lines
Pancreatic cancer is an aggressive disease with a particularly poor prognosis contributing to a substantial percentage of cancer-associated mortality rates. In the present study, the combination treatment of baicalein (BAI) and gemcitabine (GEM) was investigated to examine whether it inhibited the g...
Tallennettuna:
| Julkaisussa: | Oncol Lett |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
D.A. Spandidos
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5840621/ https://ncbi.nlm.nih.gov/pubmed/29552186 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.8043 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|